Rehman, Andrea M.
Maiteki-Sebuguzi, Catherine
Gonahasa, Samuel
Okiring, Jaffer
Kigozi, Simon P.
Chandler, Clare I. R.
Drakeley, Chris
Dorsey, Grant
Kamya, Moses R.
Staedke, Sarah G. http://orcid.org/0000-0003-2505-821X
Clinical trials referenced in this document:
Documents that mention this clinical trial
Intermittent preventive treatment of malaria delivered to primary schoolchildren provided effective individual protection in Jinja, Uganda: secondary outcomes of a cluster-randomized trial (START-IPT)
https://doi.org/10.1186/s12936-019-2954-0
Funding for this research was provided by:
Joint Global Health Trials Scheme (MR/K00736X/1)
Article History
Received: 1 July 2019
Accepted: 7 September 2019
First Online: 18 September 2019
Ethics approval and consent to participate
: The trial was approved by the Ugandan National Council for Science and Technology (UNCST Ref HS 1530), the Makerere University School of Biomedical Sciences Research & Ethics Committee (SBS REC 145), London School of Hygiene & Tropical Medicine Ethics Committee (LSHTM Ref 6509), Durham University’s School of Biological and Biomedical Sciences Ethics Committee (DU SBBS/EC/STARTv5.0/June15) and the University of California, San Francisco Committee on Human Research (UCSF CHR Ref 074826). Sponsorship and insurance were provided by the LSHTM’s Clinical Trials Sub-Committee (Ref QA380).Written informed consent to participate in the study was obtained from the child’s parent or guardian, and assent to participant was obtained from all children aged 8 years or older.
: Not applicable.
: The authors declare that they have no competing interests.